Avalon GloboCare Corp. (NASDAQ:ALBT – Get Free Report) saw a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 148,000 shares, a drop of 27.1% from the June 15th total of 202,900 shares. Currently, 3.3% of the shares of the company are short sold. Based on an average daily volume of 2,760,000 shares, the short-interest ratio is currently 0.1 days.
Avalon GloboCare Stock Performance
NASDAQ ALBT opened at $0.48 on Monday. The firm’s fifty day moving average is $0.43 and its two-hundred day moving average is $0.39. Avalon GloboCare has a one year low of $0.24 and a one year high of $1.70. The firm has a market cap of $5.36 million, a PE ratio of -0.34 and a beta of 0.32.
Avalon GloboCare (NASDAQ:ALBT – Get Free Report) last issued its quarterly earnings results on Thursday, May 30th. The company reported ($0.12) earnings per share (EPS) for the quarter. The company had revenue of $0.32 million during the quarter.
About Avalon GloboCare
Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.
See Also
- Five stocks we like better than Avalon GloboCare
- 5 Top Rated Dividend Stocks to Consider
- Top 3 Defense Stocks That Should Be on Your Radar
- Investing in Travel Stocks Benefits
- Why This Banking Stock Might Be Nearing the Bottom of Its Cycle
- Why Invest in 5G? How to Invest in 5G Stocks
- MarketBeat Week in Review – 7/8 – 7/12
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.